The Recall Desk
ModerateFDA (Devices)·Z-1320-2015·Announced 2015-04-01

Roche Recalls cobas EGFR Mutation Test Kits Due to False Positives

Roche Molecular Systems is recalling 190 kits of the cobas EGFR Mutation Test because they may produce false positive results for Exon 20 insertion mutations.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The hazard is a diagnostic error (false positive) rather than a direct physical injury or contamination.

Plain-English summary

Roche Molecular Systems, Inc. is recalling 190 kits of the cobas EGFR Mutation Test, an epidermal growth factor receptor (EGFR) gene DNA assay. The recall is limited to kit batch T08661.

The recall was initiated because the affected kits are detecting false positive results for Exon 20 insertion mutations. This issue may lead to inaccurate diagnostic information for patients.

The distribution pattern for this recall is listed as Foreign. Healthcare providers and laboratories should stop using the affected kits and contact the manufacturer for further instructions.

The recalled product

Product
cobas¿ EGFR Mutation Test epidermal growth factor receptor (EGFR) gene DNA assay
Affected units
190

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • T08661

Distribution

Distribution scope not specified by the agency.